ERBB4 confers metastatic capacity in Ewing sarcoma

ERBB4 confers metastatic capacity in Ewing sarcoma

Metastatic spread is the single-most powerful predictor of poor outcome in Ewing sarcoma (ES). Therefore targeting pathways that drive metastasis has tremendous potential to reduce the burden of disease in ES. We previously showed that activation of the ERBB4 tyrosine kinase suppresses anoikis, or d...

Full description

Bibliographic Details
Main Authors: Mendoza-Naranjo, Ariadna, El-Naggar, Amal, Wai, Daniel H, Mistry, Priti, Lazic, Nikola, Ayala, Fernanda Rocha Rojas, da Cunha, Isabela Werneck, Rodriguez-Viciana, Pablo, Cheng, Hongwei, Tavares Guerreiro Fregnani, Jose H, Reynolds, Patrick, Arceci, Robert J, Nicholson, Andrew, Triche, Timothy J, Soares, Fernando A, Flanagan, Adrienne M, Wang, Yuzhuo Z, Strauss, Sandra J, Sorensen, Poul H
Format: Online
Language:English
Published: Blackwell Publishing Ltd 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721475/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721475/

Similar Items